HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Urethral Cancer

Urethral Cancer

Urethral cancer is a rare form of cancer that develops in the urethra, the tube that carries urine from the bladder out of the body. Research on urethral cancer is challenging due to its rarity and diverse subtypes, including squamous cell carcinoma, transitional cell carcinoma, and adenocarcinoma. Current studies focus on understanding the molecular mechanisms underlying urethral cancer development, exploring targeted therapies, and improving early detection methods. Advances in genomic profiling have provided insights into the genetic alterations driving urethral cancer, paving the way for personalized treatment approaches. Additionally, clinical trials are evaluating novel immunotherapy agents and combination therapies to enhance treatment outcomes. Despite the challenges, ongoing research efforts offer hope for improved management and outcomes for individuals affected by urethral cancer.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp